A citation-based method for searching scientific literature

Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson, Yazhou Li, Iciar Aviles-Olmos, Thomas T Warner, Patricia Limousin, Andrew J Lees, Nigel H Greig, Susan Tebbs, Thomas Foltynie. Lancet 2017
Times Cited: 361



Yazhou Li, TracyAnn Perry, Mark S Kindy, Brandon K Harvey, David Tweedie, Harold W Holloway, Kathleen Powers, Hui Shen, Josephine M Egan, Kumar Sambamurti, Arnold Brossi, Debomoy K Lahiri, Mark P Mattson, Barry J Hoffer, Yun Wang, Nigel H Greig. Proc Natl Acad Sci U S A 2009
Times Cited: 412




List of shared articles



Times cited


Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine.
Angela De Iuliis, Ennio Montinaro, Giuseppe Fatati, Mario Plebani, Carlo Colosimo. Neural Regen Res 2022
3

Myeloid cells in retinal and brain degeneration.
Michelle Guo, Turner D Schwartz, Joshua L Dunaief, Qi N Cui. FEBS J 2022
3


Parkinson's disease and diabetes mellitus: common mechanisms and treatment repurposing.
Carmen M Labandeira, Arturo Fraga-Bau, David Arias Ron, Elena Alvarez-Rodriguez, Pablo Vicente-Alba, Javier Lago-Garma, Ana I Rodriguez-Perez. Neural Regen Res 2022
4

Recent Advances in Drug Therapy for Parkinson's Disease.
Hidetomo Murakami, Tomotaka Shiraishi, Tadashi Umehara, Shusaku Omoto, Yasuyuki Iguchi. Intern Med 2022
1

Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation.
Bruno Dutra Arbo, Lucia Emanueli Schimith, Michele Goulart Dos Santos, Mariana Appel Hort. Eur J Pharmacol 2022
0

Emerging Therapeutic Strategies for Parkinson's Disease and Future Prospects: A 2021 Update.
Noha A Gouda, Ahmed Elkamhawy, Jungsook Cho. Biomedicines 2022
6

Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson's Disease Mouse Model.
Zijuan Zhang, Hai Li, Yunfang Su, Jinlian Ma, Ye Yuan, Ziyang Yu, Ming Shi, Simai Shao, Zhenqiang Zhang, Christian Hölscher. Front Neurosci 2022
3

Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson's disease.
Xiaoyan Yang, Peng Feng, Rong Ji, Yiqing Ren, Wenshi Wei, Christian Hölscher. Expert Opin Ther Targets 2022
5

Gut-Brain Communication in Parkinson's Disease: Enteroendocrine Regulation by GLP-1.
Richard A Manfready, Christopher B Forsyth, Robin M Voigt, Deborah A Hall, Christopher G Goetz, Ali Keshavarzian. Curr Neurol Neurosci Rep 2022
1

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight.
Giulia Monti, Diana Gomes Moreira, Mette Richner, Henricus Antonius Maria Mutsaers, Nelson Ferreira, Asad Jan. Cells 2022
1

Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives.
Federica Ferrari, Antonio Moretti, Roberto Federico Villa. Pharmacol Ther 2022
0



DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson's Disease Rat Model.
Lingyu Zhang, Chun Li, Zijuan Zhang, Zhenqiang Zhang, Qian-Qian Jin, Lin Li, Christian Hölscher. Parkinsons Dis 2022
0

Research on developing drugs for Parkinson's disease.
Cheng-Lu Zhang, Qi-Wen Han, Nai-Hong Chen, Yu-He Yuan. Brain Res Bull 2021
8

Repurposing GLP-1 Receptor Agonists for Parkinson's Disease: Current Evidence and Future Opportunities.
Daniella Balduino Victorino, Mariana Nejm, Marcia Guimarães-Marques, Fulvio Alexandre Scorza, Carla Alessandra Scorza. Pharmaceut Med 2021
2


Novel targeted therapies for Parkinson's disease.
Theodora Ntetsika, Paraskevi-Evita Papathoma, Ioanna Markaki. Mol Med 2021
15

Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy.
Lu-Lu Bu, Yi-Qi Liu, Yan Shen, Yun Fan, Wen-Bo Yu, Dong-Lang Jiang, Yi-Lin Tang, Yu-Jie Yang, Ping Wu, Chuan-Tao Zuo,[...]. Neurotherapeutics 2021
12

The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability.
Christine Girges, Nirosen Vijiaratnam, Dilan Athauda, Grace Auld, Sonia Gandhi, Thomas Foltynie. Drugs Aging 2021
4